Association of ADAM17 Expression Levels in Patients with Interstitial Lung Disease

Volume: 49, Issue: 1-2, Pages: 134 - 145
Published: Aug 30, 2019
Abstract
A disintegrin and metalloproteinases (ADAMs) are believed to be involved in the pathogenesis of many fibrosis-related diseases. However, little is known regarding the significance of ADAM17 as a biomarker for interstitial lung disease (ILD). In this study, by using the RT-PCR, western blotting and ELISA, we detected the expression level of ADAM17 in peripheral blood mononuclear cells and serum from idiopathic pulmonary fibrosis (IPF) patients,...
Paper Details
Title
Association of ADAM17 Expression Levels in Patients with Interstitial Lung Disease
Published Date
Aug 30, 2019
Volume
49
Issue
1-2
Pages
134 - 145
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.